These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31843988)

  • 21. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
    Hladik B; Buscke F; Frost R; Rothhaar U
    PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.
    Chillon A; Zuccato D
    PDA J Pharm Sci Technol; 2019; 73(3):235-246. PubMed ID: 30651335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System.
    Jenke D
    PDA J Pharm Sci Technol; 2010; 64(6):527-35. PubMed ID: 21502063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elemental Impurities in Pharmaceutical Excipients.
    Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
    J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elemental impurities in pharmaceutical products adding fuel to the fire.
    Maithani M; Raturi R; Sharma P; Gupta V; Bansal P
    Regul Toxicol Pharmacol; 2019 Nov; 108():104435. PubMed ID: 31376414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry.
    Brown H; Mahler HC; Mellman J; Nieto A; Wagner D; Schaar M; Mathaes R; Kossinna J; Schmitting F; Dreher S; Roehl H; Hemminger M; Wuchner K
    PDA J Pharm Sci Technol; 2017; 71(2):147-162. PubMed ID: 27789803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling the Migration Behavior of Extractables from Mono- and Multilayer Polyolefin Films to Mathematically Predict the Concentration of Leachable Impurities in Pharmaceutical Drug Products. Part 2: Conservative Diffusion and Partition Coefficient Determinations.
    Mercea PV; Ossberger M; Wyrwich R; Herburger M; Barge V; Aluri R; Toşa V
    PDA J Pharm Sci Technol; 2024 Feb; 78(1):33-44. PubMed ID: 37580130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing Physical Container Closure Integrity Test Methods and Artificial Leak Methodologies.
    Peláez SS; Mahler HC; Herdlitschka C; Wertli T; Kahl M; Koulov A; Matter A; Singh SK; Widmer M; Germershaus O; Mathaes R
    PDA J Pharm Sci Technol; 2019; 73(3):220-234. PubMed ID: 30651337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 2-Errors of Inexact Identification and Inaccurate Quantitation.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):108-133. PubMed ID: 31308065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proper Accounting for Surface Area to Solution Volume Ratios in Exaggerated Extractions.
    Jenke DR; Rabinow BE
    PDA J Pharm Sci Technol; 2017; 71(3):225-233. PubMed ID: 28196915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendation of Single Time Point Leachables Testing for Lyophilized Biotechnology Products Stored in Rubber Stoppered Glass Vial Systems.
    Gallegos A; Liu J; Ronk M; Qi L; Li K; Semin D; Nashed-Samuel Y
    J Pharm Sci; 2022 Jun; 111(6):1599-1604. PubMed ID: 35257694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of extractables in processed and unprocessed polymer materials used for pharmaceutical applications.
    Stults CL; Ansell JM; Shaw AJ; Nagao LM
    AAPS PharmSciTech; 2015 Feb; 16(1):150-64. PubMed ID: 25227309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linking extractables and leachables in container/closure applications.
    Jenke DR
    PDA J Pharm Sci Technol; 2005; 59(4):265-81. PubMed ID: 16218205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On developing a process for conducting extractable-leachable assessment of components used for storage of biopharmaceuticals.
    Wakankar AA; Wang YJ; Canova-Davis E; Ma S; Schmalzing D; Grieco J; Milby T; Reynolds T; Mazzarella K; Hoff E; Gomez S; Martin-Moe S
    J Pharm Sci; 2010 May; 99(5):2209-18. PubMed ID: 20039383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Holistic Approach of Extractables and Leachables Assessment of Rubber Stoppered Glass Vial Systems for Biotechnology Products.
    Qi L; Liu J; Ronk M; Gallegos A; Fujimori K; Luo Y; Li K; Lee H; Nashed-Samuel Y
    J Pharm Sci; 2021 Nov; 110(11):3580-3593. PubMed ID: 34324943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Justification of a Risk Evaluation Matrix To Guide Chemical Testing Necessary To Select and Qualify Plastic Components Used in Production Systems for Pharmaceutical Products.
    Jenke D
    PDA J Pharm Sci Technol; 2015; 69(6):677-712. PubMed ID: 26659101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Quantitation Classifications for Extractables and Leachables.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(2):275-285. PubMed ID: 31420509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(3):348-358. PubMed ID: 32295860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective.
    Markovic I
    Expert Opin Drug Saf; 2007 Sep; 6(5):487-91. PubMed ID: 17877437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling extractable and leachable inorganic impurities in ophthalmic drug containers by ICP-MS.
    Solomon P; Nelson J
    Pharm Dev Technol; 2018 Mar; 23(3):247-254. PubMed ID: 28797192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.